Showing results (241-250 of 894) with videos related to
Sort By:
Pageof 90
Drugs in R&D|May 7, 2008
A review of the role of CpG oligodeoxynucleotides as toll-like receptor 9 agonists in prophylactic and therapeutic vaccine development in infectious diseasesKaveri Gupta, Curtis CooperDrugs in R&D|May 7, 2008
Acadesine: AICA riboside, ARA 100, arasine, GP 1 110Drugs in R&D|September 14, 2011
Cataract surgery complications: an in vitro model of toxic effects of ropivacaine and lidocaineNicola Pescosolido, Gianfranco Scarsella, Marco Tafani, et al.Drugs in R&D|July 23, 2011
Seated cuff blood pressure-lowering efficacy of an olmesartan medoxomil-based treatment regimen in patients with type 2 diabetes mellitusDean J Kereiakes, Joel M NeutelDrugs in R&D|March 18, 2011
Pharmacokinetic drug interactions with vandetanib during coadministration with rifampicin or itraconazolePaul Martin, Stuart Oliver, Jane Robertson, et al.Drugs in R&D|March 18, 2011
Comparison of dissolution profiles and serum concentrations of two lamotrigine tablet formulationsMladena Lalic, Ana Pilipovic, Svetlana Golocorbin-Kon, et al.Drugs in R&D|March 18, 2011
Pharmacokinetic profile of lesogaberan (AZD3355) in healthy subjects: a novel GABA(B)-receptor agonist reflux inhibitorMohammad Niazi, Stanko Skrtic, Magnus Ruth, et al.Drugs in R&D|October 20, 2011
Boosted tipranavir versus darunavir in treatment-experienced patients: observational data from the randomized POTENT trialMabrouk M Elgadi, Peter J PilieroDrugs in R&D|February 21, 2012
Pharmacokinetics, safety and tolerability of Bencycloquidium bromide, a novel selective muscarinic M1/M3 receptor antagonist, after single and multiple intranasal doses in healthy chinese subjects: an open-label, single-center, first-in-human studyLuning Sun, Li Ding, Yongqing Wang, et al.Drugs in R&D|March 20, 2012
In vitro dissolution profile of two commercially available iron preparationsJosé P H Patrício, Cristina Santos, Rui CerdeiraPageof 90